The Ames assay has received widespread attention from statisticians because of its popularity and importance to risk assessment. However, investigators have yetto routinely apply modem regression methods that have been available for more than a decade. We study yet another approach, the application of nonparametric regression techniques, not as the ultimate solution but rather as a framework within which to address some of the shortcomings of other methods. But nonparametric regression is itself prone to difficulties when applied to Ames assay data, as we show through the use of two examples and some simulation studies. We argue that there remains a great need for further development of statistical methods suitable to the Ames assay. It is hoped that such work can be stimulated and guided by greater collaboration between statisticians and laboratory investigators.
Introduction
The Ames (Salmonella/histidine reversion) mutagenicity assay (1, 2) In light of these advances, it might be expected that investigators would routinely apply modem methods ofanalysis. Yet, an informal scan of recent volumes of one major journal revealed that these methods are almost never used by investigators. Most inferences regarding mutagenicity seem to be based on classical methods ofanalysis (e.g., simple regression or ANOVA, multiple m-tests, etc.) or even nonstochastic methods such as the twofold rule (4) . The We should interject at this point that we strongly advocate collaboration between statisticians and laboratory investigators. We do not deem simplicity or ease of understanding on the part of nonstatisticians to be the only criterion for recommending methods of analyzing laboratory data. Proposing overly simple and statistically inefficient methods to make them palatable to statistically untrained researchers can lead to misleading results and, perhaps, distrust of statisticians. We hope that this conference, by bringing together statisticians and toxicologists, will allow toxicologists to acquire better understanding of statistical methods and help build the kind ofcollaboration that will further the interests of both fields of endeavor.
With these introductory ideas in mind, we turn now to focus specifically on the first issue, the need for further development of methods of analysis. We will not address the issue of facilitating better application. We propose a new direction for methodological development in the area of the Ames assaynonparametric regression -and present a specific example based on the smoothing spline. This paper is not meant to be the final word on statistical methods for the analysis ofAmes data, nor do we wish to imply that the present method is the only (b) Quinoline data (9 (Fig. 2b) is from a study of the mutagenicity of the chemical quinoline (9) . In this example it is not easy to ascertain the dose response because ofthe variability in the data, although both mutagenicity and a downturn due to toxicity at high doses are evident. Fitted curves are from the point rejection, nonlinear regression, quasi-likelihood, and nonparametric regression methods (see subsequent sections).
We will keep mathematics to a minimum, focusing rather on Margolin and others (9, 14) have generalized these models to incorporate multiple generation effects in the assay, fitting their models with maximum likelihood using the negative binomial distribution. In this paper we use their multigeneration model IV (9) , with three generations for mutagenesis and histidine depletion and unlimited toxicity, to generate random data for evaluating the performance ofvarious methods. The form ofthis model is (2) where [a] + = max(0,a).
Several restrictive assumptions accompany the use of HaynesEckardt models. One is that mutagenicity and toxicity are stochastically independent. If such independence does not hold (e.g., mutants have different survival rates), then a more general model may be needed. Another is the lack of metabolic and mutagenic mechanisms in the model. Indeed, one major criticism ofthe Ames assay as used for human cancer risk assessment is that it lacks the complex chemical and cellular mechanisms involved in human carcinogenesis [briefly reviewed by Weinstein (15)].
Apart from the issue ofvalidity ofthe basic model itself, other difficulties arise in the case ofspecific methods. For example, the point rejection method circumvents toxic effects by rejecting high-dose points when there is a significant downward departure from linearity. Two potential sources of bias are: a) model misspecification when the dose response is nonlinear and b) onesided (downward only) point rejection, which can occur by chance even in the absence of toxicity. The multiple generation model is theoretically quite attractive, but the choice ofgeneration times can have a substantial effect on the magnitude of the estimated potency (9) .
Although all methods have potential deficiencies in the response model, all the methods mentioned above accommodate nonconstant Poisson variance and overdispersion (with the exception ofmaximum Poisson likelihood). In practice, they seem to perform well in many examples, but more widespread use of these methods would facilitate a much-needed critical evaluation of their general applicability. In a later section, we use Monte Carlo studies to characterize, for some of these methods, circumstances in which they are most appropriate.
Nonparametric Regression
In this section we only briefly describe one approach to analyzing Ames data by nonparametric regression. Technical details will be made available elsewhere (Cologne, in preparation); a brief outline is presented in the Appendix.
Motivation
Before introducing our approach mathematically, it may be useful to motivate it from a nontechnical perspective. The hypothetical data shown in Figure 3 provide an exaggerated illustration of the concept of fitting nonparametric functions to data. Most investigators will be familiar with the use ofthe sample means plus or minus two standard errors as depicted in Figure  3a . A straight line connecting the means gives some indication of the dose response, but it is a crude and inefficient estimate. Furthermore, the initial slope estimate is based only on the first two dose levels, ignoring information about the shape ofthe dose Figure 3b shows linear and linear-quadratic Haynes-Eckardt models fit to these data. Initial slope estimates based on these models incorporate information from the entire experimental range of doses, not just the first two doses. However, neither model fits the data well; presumably they do not reflect the true mechanistic model. In addition, different models with seemingly equivalent fits to the data can produce disparate potency estimates (as is well known to occur in the case of low-dose extrapolation in the animal bioassay).
As an alternative, we consider using a general class ofmathematical functions, rather than the specific functions implied by use of the Haynes-Eckardt model. Figure 3c shows the fit of a "cubic interpolating spline," a piecewise polynomial function that connects points in a smooth fashion. (In fact, the line in Figure 3a is a linear interpolating spline.) The amount of smoothness at the dose values depends on the degrees of the polynomials (compare Figure 3c to Figure 3a) . We can add higher-order polynomial terms to make the function more smooth at the dose values. Generally, cubic splines are sufficiently smooth so that higher-order terms are not necessary, but by interpolating the means, the cubic interpolating spline again ignores sampling variability. The result is often a curve that is extremely wavy in the regions between dose values. The final step is to "penalize" the spline in such a way that it neither overfits (interpolation, leading to large variability in the estimated response) nor oversmooths (straight line regression, leading to bias in the estimated response). This is done by crossvalidation, a method that balances bias and variability by letting the data determine the optimal amount of smoothness. Figure 3d shows the fit of such a "cross-validated cubic smoothing spline" to these hypothetical data. The fitted curve more closely describes the underlying response than those in Figure 3b, 
Implementation
We have chosen to use the cubic smoothing spline (CSS) because it is visually smooth and is easily differentiated. The latter is important for computing potency, which requires calculation ofthe initial slope ofthe dose-response curve (see the next section for some discussion ofbiases in CSS estimation ofpotency). Detailed treatment ofthe CSS is available elsewhere (16, 17 
Biases in the Potency Estimator
The validity of (3r as a potency estimator depends on the unknown model A (x) because (3i estimates '(0) rather than M'N(O) [ The validity of 3,r also depends on how well a cubic spline approximates the true dose-response function g(x). Let biasa = , -u '(0) be called the "approximation bias"; this is the bias due to approximating the initial slope of A(x), using the interpolating spline fit to the true means. This bias may be calculated for specific dose-response models by simulating the model and fitting the cubic interpolating spline. Figure 4 shows 
Monte Carlo Studies
In the Monte Carlo studies we used a variety of HaynesEckardt and multigeneration models, with varying degrees of curvature and either 90% or 10% minimum survival, to obtain random Ames assay type data. All studies were based on five dose levels with relative spacing (0, 0.125, 0.25, 0.5, 1). Random Poisson or negative binomial variables were generated according to algorithm "NG" ofAhrens and Dieter (19) . Three replicates were generated at each dose. Each experiment consisted of2000 simulated data sets. Ifthere was no quadratic mutagenicity term (m2 = 0) in the model that generated the data, we fit a linear (13) . We took No = 108. All simulated models displayed substantial curvature over the wider range ofdoses produced by allowing survival to decrease to 10%, and the nonlinear regression method nearly always converged. The power of all three methods was greater than in the above cases of 90% minimum survival. The nonlinear regression method performed quite well on data generated by Haynes-Eckardt models, whereas the smoothing spline and point rejection initial slope estimates were highly sensitive to the magnitude of the quadratic term.
With multiple generation models and 10% minimum survival, the smoothing spline was the only method able to closely estimate a small positive potency (last column ofTable 2). The nonlinear regression method gave highly biased and variable initial slope estimates, whereas the point rejection method overestimated the initial slope when the true potency was small.
As an example ofthe total bias calculations for the smoothing spline (see the previous section), consider the estimate 1.65 from 2a) and quinoline (Fig. 2b) . aAverage number of retained points after point rejection.
bNumber of cases in which NR converged. As with the Monte Carlo studies, there is large bias in the point rejection slope due to an upwardly curving response in the case ofthe coal base data. However, the point rejection method is the most powerful in the case ofthe quinoline data, in which the lowdose linearity assumption appears reasonable, and all three methods gave similar estimates. The smoothing spline doseresponse estimate for the quinoline data appears strange in the high-dose region because there is a large gap with no information between the highest and next highest doses (a seemingly uninteresting region of the dose response). This points out the need to consider issues of experimental design; the same total sample size applied to a narrower dose range would provide more information concerning mutagenic potency.
Conclusions
Each of the methods we compared performed best in situations where its assumptions most closely held true. The nonlinear regression method [based on the Haynes-Eckardt model (Eq. 1)] performed well when the true model was Equation 1 and the dose range was wide enough that all of the parameters were estimable from the data. The point rejection method was quite powerful when the underlying dose response was nearly linear, but otherwise it overestimated mutagenic effects. The smoothing spline performed best in situations when the nonlinear regression was inappropriate because ofthe wrong model (e.g., with multigeneration models) and when the point rejection method was wrong due to curvature in the initial dose response (e.g., with nonlinear models and wide dose ranges). No single method performed well under all situations.
The smoothing spline approach was designed to provide an alternative to model-based regression methods when the underlying model is nonlinear and does not follow Equation 1 . We observed that, when the dose range is selected so that minimum survival is at least 90%, even multigeneration models are nearly linear over the entire dose range, so that the point rejection method produces quite reasonable results. In this sense, the smoothing spline is rather disappointing because it appears Figure 5 summarizes the need for further research into statistical methods suitable for use with the Ames assay. It emphasizes the important role that collaboration and application should play in this work. Statisticians can also contribute by advising researchers on how they can design better experiments so as to obtain the sort ofdata needed for robust analyses. Finally, it would be useful to have methods for comparing goodness of fit among the variety ofmodels discussed in this paper. It is hoped that more statisticians will become interested in these problems and that greater collaboration between statisticians and laboratory investigators will occur in the future. -alI X2 Wq= T4 X2 6
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